These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17101667)

  • 1. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
    Srivastava A; Casey H; Johnson N; Levy O; Malley R
    Infect Immun; 2007 Jan; 75(1):342-9. PubMed ID: 17101667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.
    Srivastava A; Henneke P; Visintin A; Morse SC; Martin V; Watkins C; Paton JC; Wessels MR; Golenbock DT; Malley R
    Infect Immun; 2005 Oct; 73(10):6479-87. PubMed ID: 16177320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.
    McNeela EA; Burke A; Neill DR; Baxter C; Fernandes VE; Ferreira D; Smeaton S; El-Rachkidy R; McLoughlin RM; Mori A; Moran B; Fitzgerald KA; Tschopp J; Pétrilli V; Andrew PW; Kadioglu A; Lavelle EC
    PLoS Pathog; 2010 Nov; 6(11):e1001191. PubMed ID: 21085613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBX21 participates in innate immune response by regulating Toll-like receptor 2 expression in Streptococcus pneumoniae infections.
    Woo CH; Shin SG; Koh SH; Lim JH
    Mol Oral Microbiol; 2014 Oct; 29(5):233-43. PubMed ID: 24903905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic disease.
    O'Donoghue GT; Pidgeon GP; Harmey JH; Dedrick R; Redmond HP; Bouchier-Hayes DJ
    Ir J Med Sci; 2008 Dec; 177(4):359-65. PubMed ID: 18855097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
    Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
    Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
    Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
    J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
    Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
    J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells.
    Schultz H; Hume J; Zhang DS; Gioannini TL; Weiss JP
    J Immunol; 2007 Aug; 179(4):2477-84. PubMed ID: 17675509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.
    Zhang Q; Bagrade L; Bernatoniene J; Clarke E; Paton JC; Mitchell TJ; Nunez DA; Finn A
    J Infect Dis; 2007 Apr; 195(8):1194-202. PubMed ID: 17357058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
    Dessing MC; Florquin S; Paton JC; van der Poll T
    Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.
    Malley R; Henneke P; Morse SC; Cieslewicz MJ; Lipsitch M; Thompson CM; Kurt-Jones E; Paton JC; Wessels MR; Golenbock DT
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1966-71. PubMed ID: 12569171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
    Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.
    Subramanian K; Neill DR; Malak HA; Spelmink L; Khandaker S; Dalla Libera Marchiori G; Dearing E; Kirby A; Yang M; Achour A; Nilvebrant J; Nygren PÅ; Plant L; Kadioglu A; Henriques-Normark B
    Nat Microbiol; 2019 Jan; 4(1):62-70. PubMed ID: 30420782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection.
    Alhamdi Y; Neill DR; Abrams ST; Malak HA; Yahya R; Barrett-Jolley R; Wang G; Kadioglu A; Toh CH
    PLoS Pathog; 2015 May; 11(5):e1004836. PubMed ID: 25973949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.
    Bewley MA; Naughton M; Preston J; Mitchell A; Holmes A; Marriott HM; Read RC; Mitchell TJ; Whyte MK; Dockrell DH
    mBio; 2014 Oct; 5(5):e01710-14. PubMed ID: 25293758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria.
    Wittmann I; Schönefeld M; Aichele D; Groer G; Gessner A; Schnare M
    J Immunol; 2008 Jun; 180(11):7546-52. PubMed ID: 18490755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necroptotic Cell Death Promotes Adaptive Immunity Against Colonizing Pneumococci.
    Riegler AN; Brissac T; Gonzalez-Juarbe N; Orihuela CJ
    Front Immunol; 2019; 10():615. PubMed ID: 31019504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.